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Abstract
We previously defined macrophages harvested from the peritoneal cavity of nude mice with subcutaneous human
pancreatic tumors as ‘‘tumor-educated-macrophages’’ (Edu) and macrophages harvested from mice without tumors as
‘‘naı¨ve-macrophages’’ (Naı¨ve), and demonstrated that Edu-macrophages promoted tumor growth and metastasis. In this
study, Edu- and Naı¨ve-macrophages were compared for their ability to enhance pancreatic cancer malignancy at the cellular
level in vitro and in vivo. The inhibitory efficacy of Zoledronic acid (ZA) on Edu-macrophage-enhanced metastasis was also
determined. XPA1 human pancreatic cancer cells in Gelfoam co-cultured with Edu-macrophages proliferated to a greater
extent compared to XPA1 cells cultured with Naı¨ve-macrophages (P = 0.014). XPA1 cells exposed to conditioned medium
harvested from Edu culture significantly increased proliferation (P = 0.016) and had more migration stimulation capability
(P,0.001) compared to cultured cancer cells treated with the conditioned medium from Naı¨ve. The mitotic index of the
XPA1 cells, expressing GFP in the nucleus and RFP in the cytoplasm, significantly increased in vivo in the presence of Edu-
compared to Naı¨ve-macrophages (P = 0.001). Zoledronic acid (ZA) killed both Edu and Naı¨ve in vitro. Edu promoted tumor
growth and metastasis in an orthotopic mouse model of the XPA1 human pancreatic cancer cell line. ZA reduced primary
tumor growth (P = 0.006) and prevented metastasis (P = 0.025) promoted by Edu-macrophages. These results indicate that
ZA inhibits enhanced primary tumor growth and metastasis of human pancreatic cancer induced by Edu-macrophages.
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Introduction
The tumor microenvironment (TME) plays a major role in
determining tumor behavior. We have previously shown that
stromal cells are necessary for metastasis to occur [1]. Another
indication of the role of the TME in influencing tumor behavior is
orthotopic implantation in mouse models of intact tumor tissue,
including the entire tumor stroma, which results in a much higher
metastatic rate compared to orthotopic injection of cancer cells
alone, where metastasis is rare [2,3].
Tumor-associated macrophages have been shown to correlate
with poor prognosis in several studies [4,5]. Macrophages may
promote tumor progression by chronic inflammation, matrix
remodeling, promotion of tumor-cell invasion, intravasation,
angiogenesis, and seeding at distant sites [6]. Vascular cell
adhesion molecule-1 (VCAM-1) promotes lung metastasis in
breast cancer by tethering cancer cells to lung metastasis-
associated macrophages [7,8].
Our laboratory previously compared primary and metastatic
tumor growth following the addition of either tumor-naı¨ve-
macrophages (Naı¨ve) or macrophages previously exposed to
pancreatic cancer in a mouse model, which were termed tumor-
educated-macrophages (Edu) [8].
Our previous results suggest that macrophages influence tumors
and tumors influence macrophages, and that Edu-macrophages
promote tumor progression [8].
In the present study, Edu- and Naı¨ve-macrophages were
compared for their ability to promote malignancy at the cellular
level in vitro and in vivo. The efficacy of Zoledronic acid (ZA) to
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inhibit Edu-macrophage-enhanced malignancy was also deter-
mined.
Materials and Methods
Cell line and culture conditions
The XPA1 human pancreatic cancer cell line was used in this
study which was a kind gift from Dr. Anirban Maitra at Johns
Hopkins University [6–16]. The XPA1 cell line was transformed
to stably express GFP in the nucleus and RFP in the cytoplasm
[9,17,18]. Cells were maintained in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS) and 2 mM
glutamine (Gibco-BRL, Life Technologies Inc., Grand Island,
NY). All media were supplemented with penicillin and strepto-
mycin (Gibco-BRL). Cells were cultured at 37uC with 5% CO2
[19].
Animals
NOD/SCID mice and athymic nude mice (nu/nu), 4–6 weeks,
(AntiCancer Inc., San Diego, CA) were used. Transgenic nude
C57/B6-GFP mice (AntiCancer, Inc., San Diego, CA). expressing
green fluorescent protein (GFP) under the control of the chicken b-
actin promoter and cytomegalovirus enhancer were also used [20–
23]. Mice were kept in a barrier facility under HEPA filtration.
Mice were fed with autoclaved laboratory rodent diet. All surgical
procedures and imaging were performed with the animals
anesthetized by intramuscular injection of 0.02 ml of a solution
of 50% ketamine, 38% xylazine, and 12% acepromazine maleate.
All animal studies were conducted with an AntiCancer Institu-
tional Animal Care and Use Committee (IACUC)-protocol
specifically approved for this study and in accordance with the
principals and procedures outlined in the National Institute of
Health Guide for the Care and Use of Animals under Assurance
Number A3873-1.
Subcutaneous tumor cell implantation
Human XPA1 dual-color pancreatic cancer cells were harvested
by trypsinization and washed twice with serum-free medium. Cells
(26106 in 100 ml serum-free media) were injected subcutaneously,
within 30 min of harvesting, over the flanks in transgenic nude
C57/B6-GFP mice or nontransgenic nu/nu mice between 4 and 6
weeks of age. Subcutaneous tumors were allowed to grow for 2–4
weeks until large enough for further experiments or subsequent
orthotopic implantation.
Real-time imaging of the interactions between host
macrophages and cancer cells in live mice
After the mice were anesthetized as described above, an arc-
shaped incision was made in the abdominal skin, and then
subcutaneous connective tissue was separated to free the skin flap
without injuring the epigastric cranialis artery and vein [24]. The
skin-flap was spread and fixed on a flat stand. XPA1-GFP-RFP
cells (16106 in 100 ml medium) were sprinkled over the surface of
the skin–flap of mice (Fig. 1A) [25]. Twenty-four hours later, the
inside surface of the skin-flap was directly observed with the
FV1000 confocal microscope (Olympus, Tokyo, Japan) with
excitation from semiconductor lasers at 473 nm for GFP and
559 nm for RFP excitation. Fluorescence images were obtained
using the 206/1.0 XLUMPLFLN objective [26]. The number of
phagocytosed and mitotic cancer cells were counted, and the mean
number was calculated from five visual fields at 206magnifica-
tion.
Macrophage harvest
Transgenic nude C57/B6-GFP mice with the dual-color XPA1-
GFP-RFP subcutaneous tumors were the source for Edu-
macrophages. Transgenic nude C57/B6-GFP mice without
tumors were the source for Naı¨ve-macrophages. After the mice
were anesthetized as described above, 6 ml RPMI was injected
into the intraperitoneal space of each mouse using a 10 ml syringe
and the mice were gently agitated for 5 minutes. The syringe was
then reinserted and all RPMI medium was removed and placed
into a plastic petri dish. The dishes were then incubated at 37uC
for 4 hours. RPMI medium was then removed and each plate was
washed 10–15 times with 10 ml PBS, or until all red blood cells,
fibroblasts, and other cellular debris were removed. Plates were
visualized under an IX71 fluorescence microscope (Olympus,
Tokyo, Japan) in order to confirm the presence of GFP-expressing
macrophages. Macrophages were scraped from the petri dish,
using a rubber spatula, collected with a wash of 10 ml PBS, and
centrifuged at 850 rpm for 10 minutes. PBS was then removed
and macrophages were resuspended in RPMI.
Proliferation assay using 3D culture
Naı¨ve- or Edu-macrophages were co-cultured with dual-color
XPA1-GFP-RFP cancer cells, but they were separated from each
other by Gelfoam (Pharmacia & Upjohn Company, MI, USA)
(Fig. 2A). Forty-eight hours later, images were obtained from the
surface to 200 mm depth, every 1 mm, with the FV1000 confocal
microscope. The images were stacked along the Z axis, and the
mean number of cancer cells was calculated from three visual
fields at 206magnification.
MTS proliferation assay
XPA1-GFP-RFP cells in the exponential growth phase were
trypsinized to yield a cell suspension and seeded onto 96-well
plates (16104 cells/well) in triplicate. Conditioned medium was
harvested from each type of macrophages cultured in RPMI 1640
with 10% FBS for 72 h. The culture medium was removed from
the wells with XPAI-GFP-RFP cells, and the conditioned medium
was added after the cells were allowed to adhere for 24 h. After the
plates were incubated at 37uC in 5% CO2, the MTS assay was
performed at various time points (0–72 h) using the Cell Titer 96
assay (Promega, Madison, WI, USA) according to the manufac-
turer’s instructions.
Wound healing assay
Cells were grown in 24-well plates in 500 ml medium per well
until confluence was reached. A wound was made by scratching
the cells with a 10 ml pipette tip in PBS, followed by replacement
with conditioned medium which was harvested from each
macrophage type cultured in RPMI 1640 with 10% FBS for
72 h. The control group received the same volume of fresh culture
medium without serum. The wounded monolayer was photo-
micrographed with the IX71 fluorescence microscope at different
time points (0–72 h) after being scratched. Cell migration was
assessed by measuring gap sizes in multiple fields using Image J
(National Institute of Mental Health, Bethesda, MD).
Cytotoxicity assay
Naı¨ve- or Edu-macrophages were seeded onto 6-well plates
(26105 cells/well). Zoledronic acid (ZA) (Novartis Pharmaceuticals
Corporation, NJ, USA) was added to each well after the cells were
allowed to adhere for 24 h. The final concentrations of ZA were as
follows: 0, 10, 50 and 100 mM. After 48 h, the ZA-containing
medium was removed and replaced with growth medium for 24 h.
Tumor-Educated-Macrophages Inhibited by Zoledronic Acid
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After each well was washed 5 times with 3 ml PBS, the number of
GFP-expressing macrophages was counted with the IX71 fluores-
cence microscope. The mean macrophage number was calculated
from five visual fields at 106 magnification. All measurements
were carried out in triplicate.
Orthotopic tumor implantation
A small 6- to 10-mm transverse incision was made on the left
flank of the mouse through the skin and peritoneum. The tail of
the pancreas was exposed through this incision and a single tumor
fragment (3-mm3) from a XPA1 dual-color subcutaneous tumor
was sutured to the tail of the pancreas using 8-0 nylon surgical
sutures (Ethilon; Ethicon Inc., NJ, USA). Upon completion, the
tail of the pancreas was returned to the abdomen, and the incision
was closed in one layer using 6-0 nylon surgical sutures (Ethilon)
[2,27–29].
ZA treatment of the XPA1 orthotopic nude mouse model
Nude mice were orthotopically implanted with XPA1-GFP-
RFP cells as described above. The mice were treated in the
following groups: (1) saline (vehicle/control), (2) Naı¨ve- macro-
phages (3) Edu-macrophages, (4) Edu-macrophages + ZA.
Macrophages (16106 cells in 200 ml PBS) were injected ip weekly
as previously described [8]. ZA was subcutaneously injected daily
from day 21 after tumor implantation for 4 weeks. Each treatment
arm involved 8 tumor-bearing mice. No significant effects on body
weight, morbidity, or severe toxicity were observed in any
treatment arm. Animals underwent laparotomy at 7 weeks, and
both primary tumors and metastases were imaged using the
OV100 variable magnification Small Animal Imaging System
(Olympus, Tokyo, Japan) [24] and weighed and harvested for
analysis.
Data processing and statistical analysis
PASW Statistics 18.0 (SPSS, Inc) was used for all statistical
analyses. The Student’s t-test was used to compare continuous
variables between two groups. Analysis of variance models were
used to compare multiple groups. A p value of 0.05 was considered
statistically significant for all comparisons.
Results and Discussion
Edu-macrophages stimulate cancer-cell mitosis in vivo
Dual-color XPA1-GFP-RFP cells (16106) were sprinkled over
the surface of a mouse skin-flap. Twenty-four hours later, the
inside surface of the skin-flap was directly observed with the
FV1000 confocal microscope (Olympus) (Fig. 1A). GFP-expressing
host macrophages and dual-color XPA1 cancer cells were
observed in Naı¨ve-macrophage mice (Fig. 1B) and Edu-macro-
phage mice (Fig. 1C). Cancer-cell mitosis was significantly greater
in cancer cells in Edu-macrophage mice compared to cancer cells
in Naı¨ve-macrophage mice (P=0.001) (Fig. 1E). Phagocytosis of
cancer cells tended to be greater in Naı¨ve-macrophage mice
compared to Edu-macrophage mice (P=0.061) (Fig. 1D).
Edu-macrophages stimulate proliferation of cancer cells
in vitro
Naı¨ve- or Edu-macrophage were cultured with dual-color
XPA1 cancer cells separated from each other by Gelfoam
(Fig. 2A). Forty-eight hours later, confocal microscopy images
were obtained from the surface to 200 mm depth every 1 mm and
were stacked along the Z axis (Fig. 2B). Edu-macrophage-treated
cancer cells proliferated to a greater extent compared to Naı¨ve-
macrophage-treated cancer cells (P=0.014) (Fig. 2C). Condi-
tioned medium from Edu-macrophages stimulated the prolifera-
tion of cancer cells compared to control untreated cancer cells
(24 h; P=0.001, 48 h; P=0.003, 72 h; P=0.012, respectively).
In contrast, there was no significant difference between condi-
tioned medium from Naı¨ve-macrophages and fresh medium on
proliferation of XPA1 cells (Fig. 2D).
Edu-macrophage-conditioned-medium-treated cancer cells cov-
ered a significantly larger wound area than untreated control cells
at every time point (24 h; P=0.008, 48 h; P=0.002, 72 h; P,
0.001, respectively) (Fig. 2E and 2F).
ZA inhibits XPA1 pancreatic tumor progression induced
by Edu-macrophages
Edu-macrophages promoted primary tumor growth compared
to control and Naı¨ve- macrophage (control; P=0.026, Naı¨ve;
P=0.03). Edu-macrophages also promoted metastasis compared
to control and Naı¨ve-macrophages (control; P=0.012, Naı¨ve;
P=0.015) (Fig. 3C–E). ZA has been shown to kill macrophages
and prevent metastasis [30,31]. The number of both Naı¨ve- and
Edu-macrophages were significantly reduced by ZA at every dose
in vitro (Fig. 3A and 3B). In an orthotopic mouse model of
pancreatic cancer, ZA significantly suppressed Edu-macrophage,
stimulated tumor growth, and prevented metastasis compared to
the mice treated with only Edu-macrophages (primary tumor;
P=0.006, metastasis; P=0.025) (Fig. 3C–E).
In our previous study, GFP-expressing macrophages from GFP
transgenic nude mice with a subcutaneous BxPC3-RFP human
pancreatic tumor were used as a source of Edu-macrophages and
compared to Naı¨ve-macrophages from the transgenic GFP nude
mice without tumors. When the Edu- or Naı¨ve-macrophages were
then implanted into nude mice with BxPC-3-RFP growing
orthotopically, the Edu-macrophages stimulated tumor growth
and metastasis to a greater degree than Naı¨ve-macrophages [8].
In another previous study, human peripheral-blood mononu-
clear cells were exposed to conditioned medium from BxPC-3
human pancreatic cancer cells, in normal or high glucose levels.
The pancreatic cancer cells educated the macrophages to be more
invasive in vitro, which was further enhanced by hyperglycaemia
[32].
Figure 1. Imaging of the interactions between host macrophages and cancer cells in live mice. (A) Scheme of imaging the interactions
between host macrophages and cancer cells in live mice. GFP nude mice with dual-color XPA1 subcutaneous tumors were the source of Edu-
macrophages. GFP nude mice without tumors were the source of Naı¨ve-macrophage. A skin-flap was spread and fixed on a flat stand. XPA1-GFP-RFP
cells (16106 in 100 ml medium) were sprinkled over the surface of the skin–flap of mice. Twenty-four hours later, the inside surface of the skin-flap
was directly observed with the FV1000 confocal microscope (Olympus). Scale bars: 10 mm. GFP host macrophages and dual-color XPA1 cancer cells
were observed in Naı¨ve-macrophage mice (B) and Edu-macrophage mice (C). Phagocytosed cancer cells (white arrowheads) and mitotic cancer cells
(yellow arrowheads) were detected in both groups. The mean values of phagocytosized and mitotic cancer cells were calculated from four fields with
a 206magnification objective (D and E). Mitosis significantly increased in cancer cells in mice with Edu-macrophages compared to cancer cells in
mice with Naı¨ve-macrophages (P = 0.001). More phagocytosis of cancer cells tended to be detected in mice with Naı¨ve-macrophages, (P = 0.061).
Scale bars: 20 mm.
doi:10.1371/journal.pone.0103382.g001
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Figure 2. Conditioned medium from Edu-macrophages promotes pancreatic cancer cell proliferation and migration. (A) A schema of
the separated co-culture system using Gelfoam. Naı¨ve- or Edu-macrophages were co-cultured with dual-color XPA1 GFP-RFP cancer cells, but they
were separated from each other by Gelfoam. Forty-eight hours later, images were obtained from the surface to 200 mm depth, every 1 mm, and
Tumor-Educated-Macrophages Inhibited by Zoledronic Acid
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In another previous study, ZA reduced the macrophage-
induced invasiveness of breast cancer cells. ZA affected macro-
phages but not the cancer cells [33].
Another previous study showed that both peritoneal and breast-
tumor associated macrophages rapidly took up ZA in vivo, further
suggesting macrophages are a target of the anti-tumor efficacy of
ZA [34].
In another previous study, ZA directly caused apoptosis on
pancreatic carcinoma cells and inhibited their invasiveness and as
well as making the pancreatic cancer cells more vulnerable to T-
cell attack [35].
were stacked along the Z axis. (B) Representative Z-stack image using a 206magnification objective. (C) The mean number of cancer cells was
calculated from three fields of Z-stack images with the 206magnification objective. The number of cancer cells treated with Edu-macrophages
increased compared to the number of cancer cells treated with Naı¨ve-macrophages (P = 0.014). (D) MTS proliferation assay. Conditioned medium was
harvested from each type of macrophage cultured in RPMI without serum for 72 h. The culture medium from the cancer cells was removed from the
wells and the conditioned medium was added. Viable cancer cell numbers are indicated with the MTS assay at various time points. The line graph
indicates the relative proliferation rate of each group. The proliferation rate of Edu-macrophage-condition-medium-treated cancer cells was
significantly higher than control or Naı¨ve-macrophage-conditioned-medium-treated cancer cells. Black diamonds: Naı¨ve; white square: Edu, white
triangle: control group. * P,0.05, ** P,0.01 (vs. control group). (E) Wounded areas were measured for 72 hours after scratching the monolayer of
cancer cells and treatment with the conditioned medium from each type of macrophage. (F) Edu-macrophage-conditioned medium-treated cells
covered a significantly larger wound area than other groups at every time point. Charts are plots of wounded areas of each group measured with
ImageJ of three random areas in 3 days. Data from three repeat experiments are presented as mean 6 SD (n = 5). * P,0.05, ** P,0.01 (vs. control
group).
doi:10.1371/journal.pone.0103382.g002
Figure 3. ZA inhibits Edu-macrophages and tumor progression induced by Edu macrophages in the orthotopic XPAI pancreatic
cancer mouse model. (A) Representative fluorescence images of Edu-macrophages after ZA treatment. Scale bars: 10 mm. (B) Bar graphs of the
number of Naı¨ve- or Edu-macrophages after ZA treatment in vitro. The numbers of both Naı¨ve- and Edu-macrophages treated with ZA were
significantly reduced at every dose. ZA killed both Naı¨ve and Edu in a dose-dependent manner. ** P,0.01 (vs. control group). (C) Intravital imaging of
XPA1-RFP tumor-bearing mice at the termination of the experiment. Scale bars: 10 mm. (D) The primary tumor weight of Edu-macrophage-treated
mice were significantly increased compared to control or Naı¨ve-macrophage-treated mice (control: P = 0.026; Naı¨ve: P = 0.03, respectively). The
primary tumor weight of Edu-macrophage + ZA-treated mice were significantly decreased compared to Edu-macrophage-treated mice (P = 0.006). *
P,0.05, ** P,0.01. (E) The metastasis weight of Edu-macrophage-treated mice were significantly increased compared to control or Naı¨ve-
macrophage-treated mice (control; P = 0.012, Naı¨ve; P = 0.015, respectively). No metastasis was detected in Edu + ZA-treated mice. There was a
significant difference between Edu and Edu + ZA-treated mice (P = 0.025). * P,0.05.
doi:10.1371/journal.pone.0103382.g003
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The present study used subcellular imaging techniques we have
previously developed [36] to directly image that Edu-macrophages
have reduced phagocytosis ability and can directly simulate mitosis
of the cancer cells, as visualized in real time. Unlike previous
studies, evaluating the efficacy of ZA, the present report used an
orthotopic metastatic mouse model to demonstrate the effect of
ZA on the stimulation by Edu-macrophages on metastasis as well
as on the primary tumor. In the present study, the macrophages
were isolated from the peritoneal cavity from tumor-bearing or
control mice, far from the tumor and administered systemically.
The results indicated that tumors had distant affect on macro-
phages and vice versa and that ZA could systemically inhibit such
effects.
ZA reduced Edu-stimulated primary tumor growth and
metastasis to approximately control values suggesting the major
ZA effect was on the Edu-macrophages, although a relatively
minor direct inhibitory effect on the tumor itself by ZA cannot be
ruled out as described in a previous study [35]. ZA has been
previously reported to have greater macrophage killing efficacy
than other bisphosphonates and was therefore chosen for the
present study [37].
The present study indicated that Edu-macrophages promote
malignancy. This was shown by the stimulatory effect of Edu-
macrophages on cancer-cell mitosis and subsequent proliferation
as well as on metastasis. As we stated previously [8], tumors can
affect macrophages which in turn can affect tumors. Tumor
progression induced by Edu-macrophages was inhibited by ZA,
which inhibited Edu-macrophage-enhanced primary tumor
growth and prevented metastasis. The mechanisms by which
Edu-macrophages stimulate cancer-cell proliferation and progres-
sion will be the subject of a future study.
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